Alkaline phosphatase activity was higher in IDDM (P
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Our purpose was to investigate the effect of different zinc metabolic disorders on alkaline phosphatase activity.
📊
Key Findings & Data:Serum zinc, glucose and alkaline phosphatase activity were studied in 32 patients with liver cirrhosis, 30 with chronic renal failure and 42 with insulin-dependent diabetes mellitus (IDDM) compared to 42 healthy volunteers.
💡
Conclusion & Impact:Alkaline phosphatase activity was higher in IDDM (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Our purpose was to investigate the effect of different zinc metabolic disorders on alkaline phosphatase activity. Serum zinc, glucose and alkaline phosphatase activity were studied in 32 patients with liver cirrhosis, 30 with chronic renal failure and 42 with insulin-dependent diabetes mellitus (IDDM) compared to 42 healthy volunteers. Serum glucose concentration was significantlyhigher (P < 0.001) in IDDM and liver cirrhosis patients (P < 0.05) compared to the controls. Serum zinc concentrations tended to be lower in all different diseases but did not reach statistical significance. Alkaline phosphatase activity was higher in IDDM (P
🔖
Cite This Article
KECHRID, Z., KENOUZ, R. (2022). Determination of alkaline phosphatase activity in patients with deifferent zinc metabolic disorders. Turkish Journal of Medical Sciences, Cilt: 33 - Sayı: 6, 387–391. https://ajindex.com/articles/612123
1 Keillin D, Mann J. Carbonic anhydrase, purification and nature of the enzyme. Biochem 34: 1163-1171, 1940. 2. Melinkeri RR, Sontakke AN, Kulkarni AM. Serum zinc and zinc containing enzymes in diabetes mellitus. Ind Med Sci 44: 173- 177, 1990. 3. Scrutton MC, Wu CW, Goldthwait DA. The presence and possible role of zinc in RNA polymerase obtained from Escherichia coli. Proc Natl Sci 68: 2497, 1971. 4. Jeffery J, Chesters J, Mills C et al. Sorbitol dehydrogenase is a zinc enzyme. Embo 3: 367, 1984. 5. Luecke RW, Olman ME, Baltzer BV. Zinc deficiency in the rat: Effect on serum alkaline phosphatase activities. Nutr 94: 344- 350, 1968. 6. Dahlheim H, White CL, Rothemund J. Effect of zinc depletion on angiotensin I converting enzyme in arterial walls and plasma of the rat. Metab 15: 125-129, 1989. 7. Prasad AS, Oberleas D. Changes in activity of zinc dependent enzymes in zincÐdeficient tissues of rats. J Appl Physiol 31: 842- 851, 1971. 8. Nishita T, Igarashi S, Asari M. Determination of carbonic anhydrase by enzyme-immunoassay in liver, muscle and serum of male rats with streptozotocin-induced diabetes mellitus. Int Bioch-cell Biol 27: 359-364, 1995. 9. Sheldon WL, Aspillaga MO, Smith PA, et al. The effect of oral iron supplementation on zinc and magnesium levels during pregnancy. Brit J Obstet Gynaec 92: 892-898, 1985. 10. Picciano MF, Guthine HA. Determination of concentration and variations of copper, iron and zinc in human milk. Fed Proc Fed Am Soc Exp Biol 32: 929, 1973. 11. Prasad AS, Schulert AR, Sandstead HH et al. Zinc, iron and nitrogen content of sweat in normal and deficient subjects. Lab Clin Med 62: 84-89, 1963. 12. Kinlaw WB, Levine AS, Morley JE et al. Abnormal zinc metabolism in type II diabetes mellitus. Am Med 75: 273-277, 1983. 13. Chausmer AB. Zinc, insulin and diabetes. Am Coll Nutr 17: 109- 115, 1998. 14. Prasad AS, Oberleas D, Halstead JA. Determination of zinc in biological fluids by atomic absorption spectrophotometry in normal and cirrhotic subjects. Clin Med 66: 508-515, 1965. 15. Marchesini G, Bugianesi E, Ronchi M et al. Zinc supplementation improves glucose disposal in patients with cirrhosis. Metab. 47: 792-798, 1998. 16. Kiilerich S, Christiansen C, Christensen MS, Naestoft J. Zinc metabolism in patients with chronic renal failure during treatment with 1,25-dihydroxycholecalciferol: a controlled therapeutic trial. Clin Nephrol 15: 23-27, 1981. 17. Wolman SLI, Anderson H, Marliss EB, Jeebhoy KN. Zinc in total parenteral nutriti